Inotrem
Biopharmaceutical company discovering and developing first-in-class immunotherapies for the treatment of inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€20—30m (Dealroom.co estimates Feb 2020.)
Company register number 791682172
Paris Île-de-France (HQ)
Authorizing premium user...